2010•Unpublished venueRequires access

The Clinical Effectiveness Of Thalidomide Combined With Low Dose Dexamethasone On Multiple Myeloma

WU Jiaqing

Open publisher page 0 citations

Abstract

Objective To observe the effectiveness of thalidomide combined with low dose dexamethasone on patients with multiple myeloma (MM).Methods 16 cases with MM were enrolled for studies.Among them,9 cases are initial treament and 7 cases are relapsed or/ and refractory patient s.The dosage of thalidomide was 150mg/d,the administerd dosage of dexamethasone was 10~20 mg/dfor d 1-4 ,d 9-12 ,d 17-20 every month.Results Among the 16 evaluable patients,3 of them achieved complete remission (CR),6 of them achieved partial remission ( PR), 3 of them showed partial improving and 4 of them had no effects. Side effects could been tolerate.Conclusion Thalidomide Combined With Low Dose Dexamethasone might be effective in these patients with relapsed or/ and refractory MM,as well as these patients with initial treatment MM.

About this research paper

What this paper is about

Objective To observe the effectiveness of thalidomide combined with low dose dexamethasone on patients with multiple myeloma (MM).Methods 16 cases with MM were enrolled for studies.Among them,9 cases are initial treament and 7 cases are relapsed or/ and refractory patient s.The dosage of thalidomide was 150mg/d,the administerd dosage of dexamethasone was 10~20 mg/dfor d 1-4 ,d 9-12 ,d 17-20 every month.Results Among the 16 evaluable patients,3 of them achieved complete remission (CR),6 of them achieved partial remission ( PR), 3 of them showed partial improving and 4 of them had no effects. Side effects could been tolerate.Conclusion Thalidomide Combined With Low Dose Dexamethasone might be effective in these patients with relapsed or/ and refractory MM,as well as these patients with initial treatment MM.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effectiveness of thalidomide combined with low dose dexamethasone on patients with multiple myeloma (MM).Methods 16 cases with MM were enrolled for studies.Among them,9 cases are initial treament and 7 cases are relapsed or/ and refractory patient s.The dosage of thalidomide was 150mg/d,the administerd dosage of dexamethasone was 10~20 mg/dfor d 1-4 ,d 9-12 ,d 17-20 every month.Results Among the 16 evaluable patients,3 of them achieved complete remission (CR),6 of them achieved partial remission ( PR), 3 of them showed partial improving and 4 of them had no effects. Side effects could been tolerate.Conclusion Thalidomide Combined With Low Dose Dexamethasone might be effective in these patients with relapsed or/ and refractory MM,as well as these patients with initial treatment MM.

Key concepts: Thalidomide, Dexamethasone, Refractory (planetary science), Medicine, Multiple myeloma, Internal medicine, Gastroenterology, Complete remission

Related papers

Back to paper searchBrowse research topicsOriginal source
The Clinical Effectiveness Of Thalidomide Combined With Low Dose Dexamethasone On Multiple Myeloma — Research Paper | ScholarLens